Loading clinical trials...
Loading clinical trials...
Enhanced external counterpulsation (EECP) is a noninvasive, non-pharmacologic intervention proven to increase nitric oxide bioavailability in patients with coronary artery disease. Although EECP showe...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Nanjing Medical University
Collaborators
NCT07101289 · Congestive Heart Failure Chronic
NCT06216847 · Coronary Heart Disease (CHD)
NCT07149688 · Atrial Fibrillation (AF), Hypertension, and more
NCT06786416 · Cardiac Diseases, Cardio-pulmonary Bypass, and more
NCT07186582 · Coronary Artery Disease, Ischemic Heart Disease (IHD), and more
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions